These research findings present new perspectives and approaches to treating adolescent depression, indicating that by regulating the expression level of HMGB1, it may be possible to significantly improve depressive symptoms in patients, bringing new breakthroughs to clinical treatment of depression. The gene discussed is HMGB1; the disease is depressive symptom measurement.